[PAR] [TLE] The Woodlands, Texas [SEP] The Woodlands is a master-planned community and census-designated place (CDP) in the U.S. state of Texas in the Houston–The Woodlands–Sugar Land metropolitan area.  According to The Woodlands Development Company, the population was 107,769 as of a January 2014 estimate , an increase of 93.7% over its population of 55,649 at the 2000 census. [PAR] [TLE] Lexicon Pharmaceuticals [SEP] Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering and developing breakthrough treatments for human disease.  The company was founded in 1995 in The Woodlands, Texas under the name Lexicon Genetics, Incorporated by co-founders Arthur T Sands, Ray B Webb and.  The company has used its patented mouse gene knockout technology and extensive in vivo screening capabilities to study nearly 5,000 genes in its Genome5000 program and has identified over 100 potential therapeutic targets.  Lexicon has advanced multiple drug candidates into human clinical trials and has a broad and diverse pipeline of drug targets behind its clinical programs.  Lexicon is pursuing drug targets in five therapeutic areas including oncology, gastroenterology, immunology, metabolism, and ophthalmology.
[PAR] [TLE] The Woodlands , Texas [ SEP ] The Woodlands is a master - planned community and census - designated place ( CDP ) in the U.S. state of Texas in the Houston – The Woodlands – Sugar Land metropolitan area . According to The Woodlands Development Company , the population was 107,769 as of a January 2014 estimate , an increase of 93.7 % over its population of 55,649 at the 2000 census . [PAR] [TLE] Lexicon Pharmaceuticals [ SEP ] Lexicon Pharmaceuticals , Inc. is a biopharmaceutical company engaged in discovering and developing breakthrough treatments for human disease . The company was founded in 1995 in The Woodlands , Texas under the name Lexicon Genetics , Incorporated by co - founders Arthur T Sands , Ray B Webb and . The company has used its patented mouse gene knockout technology and extensive in vivo screening capabilities to study nearly 5,000 genes in its Genome5000 program and has identified over 100 potential therapeutic targets . Lexicon has advanced multiple drug candidates into human clinical trials and has a broad and diverse pipeline of drug targets behind its clinical programs . Lexicon is pursuing drug targets in five therapeutic areas including oncology , gastroenterology , immunology , metabolism , and ophthalmology .
By what percentage did the population of the town where where Lexicon Pharmaceuticals is located increase by from 2000 to 2014?
By what percentage did the population of the town where where Lexicon Pharmaceuticals is located increase by from 2000 to 2014 ?
93.7%
93.7%